Back
   
 


Hepatitis Education for Opioid Treatment Providers

Sunday, October 21, 2007
Time: 1:00 PM – 4:00 PM

Susan Simon
Hepatitis C Association
Scotch Plains, NJ

Hepatitis C Virus (HCV) is considered the most common blood-borne infection in the United States . There are approximately 5 million people infected. Injection drug use accounts for more than two-thirds of all new infections in the United States . OTPs, needle and syringe exchange programs, and comprehensive risk-modifying educational programs have been shown to be effective in preventing HIV transmission and are likely to be useful for decreasing HCV transmissions.

This training will provide participants information on:

  • Hepatitis C and how it affects the liver
  • Hepatitis C transmission and risk factors
  • Diagnostic tests
  • Natural history and progression of Hepatitis C and HIV/HCV co-infection
  • Treatment options
  • Barriers to treatment
  • How to find community resources

Sponsored by the American Association for the Treatment of Opioid Dependence, Inc.

Supported by the Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment.

AATOD Conference Contacts
C/O Talley Management Group, Inc.

Cheryl Gallagher, Meeting Manager, aatod@talley.com
Wendy Stevens, Trade Show Manager, wstevens@talley.com
Sue Parker, Sales Associate, sparker@talley.com

19 Mantua Road
Mt. Royal, New Jersey 08061
Phone: 856-423-3091
Fax: 856-423-3420